Review
Published on 05 Jul 2022
Therapeutic Strategies For Tay-Sachs Disease
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.906647
- 27,746 views
- 19 citations
Type at least 3 characters
570 articles
Articles
Original Research
Published on 05 Jul 2022
Comprehensive Assessment of Indian Variations in the Druggable Kinome Landscape Highlights Distinct Insights at the Sequence, Structure and Pharmacogenomic Stratum
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.858345
- 3,909 views
- 1 citation
Original Research
Published on 30 Jun 2022
Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.931531
- 4,415 views
- 7 citations
Original Research
Published on 29 Jun 2022
A Computational Framework to Characterize the Cancer Drug Induced Effect on Aging Using Transcriptomic Data
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.906429
- 2,434 views
- 3 citations
Original Research
Published on 28 Jun 2022
Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.935995
- 4,320 views
- 8 citations
Original Research
Published on 28 Jun 2022
Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.918493
- 7,221 views
- 13 citations
Brief Research Report
Published on 24 Jun 2022
Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.939313
- 4,646 views
- 11 citations
Review
Published on 16 Jun 2022
Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.912618
- 4,577 views
- 19 citations
Original Research
Published on 15 Jun 2022
Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.930470
- 6,044 views
- 17 citations
Brief Research Report
Published on 08 Jun 2022
Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav–Related Liver Injury
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.882962
- 2,838 views
- 1 citation
Editorial
Published on 20 May 2022
Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.928527
- 2,424 views
- 3 citations
Perspective
Published on 18 May 2022
Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.885259
- 4,316 views
- 17 citations
Original Research
Published on 02 May 2022
Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.817020
- 2,193 views
- 3 citations
Mini Review
Published on 25 Apr 2022
An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.886377
- 10,424 views
- 34 citations
Review
Published on 20 Apr 2022
Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.832048
- 21,833 views
- 35 citations
Brief Research Report
Published on 14 Apr 2022
Single Nucleotide Variants as Proxies for HLA-A*31:01 in Native American Populations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.849136
- 2,447 views
- 4 citations